Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation
β Scribed by Kathryn M. Greven; Daniel W. Williams III; John W. Keyes Jr.; W. Fred McGuirt; Nut E. Watson Jr.; Marcus E. Randall; Milton Raben; Kim R. Geisinger; James O. Cappellari
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 705 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## __Background__. We assessed the role of ^18^Fβfluoroβdeoxyβglucose positron emission tomography (PET) in detecting head and neck squamous cell carcinoma (HNSCC) after definitive chemoradiotherapy (CRT). ## __Methods__. A prospective study presented 80 PET before and after CRT for
## Abstract ## Background A single institution study was undertaken to evaluate the role of positron emission tomography (PET) scans with fluorodeoxyglucose (FDG) prior to radiation and following radiation. ## Methods Fortyβfive patients with head and neck cancers were evaluated with FDGβPET sca
## Abstract __Background__. Positron emission tomography (PET) provides a noninvasive modality for evaluating the biochemical processes of normal and pathologic tissue. Preliminary reports of Fβ18 fluorodeoxyglucose (FDG) PET indicate its potential usefulness in evaluating head and neck tumors. The
## Abstract ## Background. Residual structural abnormalities after definitive treatment of head and neck squamous cell carcinoma (HNSCC) are common and pose difficult management problems. The usefulness of fluorineβ18 fluorodeoxyglucose positron emission tomography (FDG PET) to supplement conventi
Background. Comparison of the diagnostic validity of positron emission tomography (PET) alone with integrated PET and CT (PET/CT) in the search for occult primary tumors in patients with cancer of unknown primary (CUP) site in the head and neck. Methods. Thirty-nine consecutive patients with clinic